There were 643 press releases posted in the last 24 hours and 148,985 in the last 365 days.

Erythropoietin Market 2016 is Estimated to Grow at 1.0% CAGR Forecast to 2020

PUNE, INDIA, September 15, 2016 /EINPresswire.com/ -- Erythropoietin Market 2016

COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/464916-global-market-for-erythropoietin-2015-2020-market-for-erythropoietin-2015-2020

This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs.
The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia particularly in kidney diseases and cancer globally.

For more information or any query mail at sales@wiseguyreports.com

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

The major players in the biologic erythropoietin drug market are, Amgen, Inc., Johnson & Johnson and Hoffmann-LA Roche. Sandoz (subsidiary of Novartis International AG), Hospira (subsidiary of Pfizer, Inc.), Biocon, Biosidus, 3SBio, are some of the major biosimilar players across regions.

GET A SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/464916-global-market-for-erythropoietin-2015-2020-market-for-erythropoietin-2015-2020

Table Of Contents – Major Key Points

CHAPTER: ONE
INTRODUCTION
OBJECTIVES
SCOPE
DATA SOURCES DISCLAIMER
CHAPTER: TWO
SUMMARY
CHAPTER: THREE
OVERVIEW DEFINITION EPO DRUG BY TYPE BIOLOGICS
Epoietin-alfa
Epoietin-beta
Darbepoietin-alfa
Others
BIOSIMILARS
Epoietin-zeta
Epoietin-omega
Others
APPLICATION
End stage renal disease
Pre-dialysis
Oncology
Others
SIBE EFFECTS OF ERYTHROPOIETIN
CHAPTER: FOUR
FORECASTING
GLOBAL ERYTHROPOIETIN MARKET Global EPO Biologics Drugs Global EPO Biosimilars Drugs EPO BIOLOGIC DRUG MARKET BY TYPE Epoietin-alfa
Epoietin-beta
Darbepoietin-alfa
Others
EPO BIOLOGIC MARKET BY DRUG Epogen Procrit Eprex Mircera NeoRecromon Aranesp Others
EPO BIOSIMILARS DRUG MARKET BY TYPE Epoetin-zeta Epoetin-omega Others
EPO BIOSIMILAR MARKET BY DRUG Retacrit Binocrit Abseamed EPIAO HEMAX Epoetin-alfa BS Xue Da Sheng Others
EPO DRUG MARKET BY HALF LIFE Long Acting EPO Short Acting EPO
GLOBAL ERYTHROPOIETIN DRUG MARKET BY APPLICATION
End Stage Renal Disease (ESRD) Oncology Diseases Pre-dialysis Others
GLOBAL ERYTHROPOEITIN MARKET SEGMENTATION, BY GEOGRAPHY
North America
Europe Asia pacific South America ROW

GLOBAL ERYTHROPOEITIN NORTH AMERICAN MARKET SUB-SEGMENTATION
U.S
Mexico
Canada

GLOBAL ERYTHROPOEITIN EUROPE MARKET SUB-SEGMENTATION
EU-5
Nordic
Russia
Others

GLOBAL ERYTHROPOEITIN ASIA-PACIFIC MARKET SUB-SEGMENTATION
China
India
Japan
Australia
Others

GLOBAL ERYTHROPOEITIN SOUTH AMERICAN MARKET SUB-SEGMENTATION
Brazil
Argentina
Others

…. CONTINUED

For more information or any query mail at sales@wiseguyreports.com

GET EXCLUSIVE DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/464916-global-market-for-erythropoietin-2015-2020-market-for-erythropoietin-2015-2020

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here